NCT04104763View on ClinicalTrials.gov

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 8, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

September 30, 2021

Conditions
Osteofibrous Dysplasia
Interventions
BEHAVIORAL

study of osteofibrous dysplasia features

obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potential and risk of progression to adamantinoma.

Trial Locations (1)

40136

Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli, Bologna

All Listed Sponsors
lead

Istituto Ortopedico Rizzoli

OTHER

NCT04104763 - Osteofibrous Dysplasia (Kempson-Campanacci's Disease) | Biotech Hunter | Biotech Hunter